Special clinical interests in prostate brachytherapy, urological cancer, lymphoma, skin cancer, benign diseases suitable for radiotherapy and clinical research (TROG)
Professor David Christie is based at the Gold Coast and attends GenesisCare treatment centres at Tugun and Southport. He also attends clinics at Pindara Private Hospital and in Northern NSW (Byron Bay and Tweed Hospital).
David qualified in Medicine from New Zealand’s University of Otago in 1987 and completed Radiation Oncology training in Sydney in 1995, at which time he moved to Queensland and commenced full-time practice. David has experience in treating all cancers that require radiotherapy but has a special interest in urological cancer and lymphoma, including brachytherapy for prostate cancer.
He is actively involved in research including national and international clinical trials. He is the editor of a Radiation Oncology medical journal and has published over 150 research papers. He has research and teaching roles with the University of New England as well as Bond and Griffith Universities.
Special clinical interests include urological cancer (including prostate brachytherapy), skin cancer (including wide field radiotherapy), benign diseases (including dupuytren’s disease), lymphoma and patients eligible for clinical trials.
He has maintained an interest in cancer research through links with Griffith and Bond Universities as well as the University of New England.
He is an active contributor to several clinical trial organisations including TROG and has published over 150 publications which are accessible online.
He is the radiotherapy editor for the only Radiation Oncology medical journal that is based in Australia, JMIRO.
Consults at:
Tugun
Southport
Pindara
Tweed Hospital, Byron Bay